Clinical practice guidelines for the management of patients with histoplasmosis: 2007 Update by the Infectious Diseases Society of America

L. Joseph Wheat, Alison Gail Freifeld, Martin B. Kleiman, John W. Baddley, David S. McKinsey, James E. Loyd, Carol A. Kauffman

Research output: Contribution to journalReview article

670 Citations (Scopus)

Abstract

Evidence-based guidelines for the management of patients with histoplasmosis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous treatment guidelines published in 2000 (Clin Infect Dis 2000; 30:688-95). The guidelines are intended for use by health care providers who care for patients who either have these infections or may be at risk for them. Since 2000, several new antifungal agents have become available, and clinical trials and case series have increased our understanding of the management of histoplasmosis. Advances in immunosuppressive treatment for inflammatory disorders have created new questions about the approach to prevention and treatment of histoplasmosis. New information, based on publications from the period 1999-2006, are incorporated into this guideline document. In addition, the panel added recommendations for management of histoplasmosis in children for those aspects that differ from aspects in adults.

Original languageEnglish (US)
Pages (from-to)807-825
Number of pages19
JournalClinical Infectious Diseases
Volume45
Issue number7
DOIs
StatePublished - Oct 22 2007

Fingerprint

Histoplasmosis
Practice Management
Practice Guidelines
Guidelines
Antifungal Agents
Immunosuppressive Agents
Health Personnel
Publications
Patient Care
Therapeutics
Clinical Trials
Infection

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Clinical practice guidelines for the management of patients with histoplasmosis : 2007 Update by the Infectious Diseases Society of America. / Wheat, L. Joseph; Freifeld, Alison Gail; Kleiman, Martin B.; Baddley, John W.; McKinsey, David S.; Loyd, James E.; Kauffman, Carol A.

In: Clinical Infectious Diseases, Vol. 45, No. 7, 22.10.2007, p. 807-825.

Research output: Contribution to journalReview article

Wheat, L. Joseph ; Freifeld, Alison Gail ; Kleiman, Martin B. ; Baddley, John W. ; McKinsey, David S. ; Loyd, James E. ; Kauffman, Carol A. / Clinical practice guidelines for the management of patients with histoplasmosis : 2007 Update by the Infectious Diseases Society of America. In: Clinical Infectious Diseases. 2007 ; Vol. 45, No. 7. pp. 807-825.
@article{1df5247e5725488dacc4ad129ccc504c,
title = "Clinical practice guidelines for the management of patients with histoplasmosis: 2007 Update by the Infectious Diseases Society of America",
abstract = "Evidence-based guidelines for the management of patients with histoplasmosis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous treatment guidelines published in 2000 (Clin Infect Dis 2000; 30:688-95). The guidelines are intended for use by health care providers who care for patients who either have these infections or may be at risk for them. Since 2000, several new antifungal agents have become available, and clinical trials and case series have increased our understanding of the management of histoplasmosis. Advances in immunosuppressive treatment for inflammatory disorders have created new questions about the approach to prevention and treatment of histoplasmosis. New information, based on publications from the period 1999-2006, are incorporated into this guideline document. In addition, the panel added recommendations for management of histoplasmosis in children for those aspects that differ from aspects in adults.",
author = "Wheat, {L. Joseph} and Freifeld, {Alison Gail} and Kleiman, {Martin B.} and Baddley, {John W.} and McKinsey, {David S.} and Loyd, {James E.} and Kauffman, {Carol A.}",
year = "2007",
month = "10",
day = "22",
doi = "10.1086/521259",
language = "English (US)",
volume = "45",
pages = "807--825",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Clinical practice guidelines for the management of patients with histoplasmosis

T2 - 2007 Update by the Infectious Diseases Society of America

AU - Wheat, L. Joseph

AU - Freifeld, Alison Gail

AU - Kleiman, Martin B.

AU - Baddley, John W.

AU - McKinsey, David S.

AU - Loyd, James E.

AU - Kauffman, Carol A.

PY - 2007/10/22

Y1 - 2007/10/22

N2 - Evidence-based guidelines for the management of patients with histoplasmosis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous treatment guidelines published in 2000 (Clin Infect Dis 2000; 30:688-95). The guidelines are intended for use by health care providers who care for patients who either have these infections or may be at risk for them. Since 2000, several new antifungal agents have become available, and clinical trials and case series have increased our understanding of the management of histoplasmosis. Advances in immunosuppressive treatment for inflammatory disorders have created new questions about the approach to prevention and treatment of histoplasmosis. New information, based on publications from the period 1999-2006, are incorporated into this guideline document. In addition, the panel added recommendations for management of histoplasmosis in children for those aspects that differ from aspects in adults.

AB - Evidence-based guidelines for the management of patients with histoplasmosis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous treatment guidelines published in 2000 (Clin Infect Dis 2000; 30:688-95). The guidelines are intended for use by health care providers who care for patients who either have these infections or may be at risk for them. Since 2000, several new antifungal agents have become available, and clinical trials and case series have increased our understanding of the management of histoplasmosis. Advances in immunosuppressive treatment for inflammatory disorders have created new questions about the approach to prevention and treatment of histoplasmosis. New information, based on publications from the period 1999-2006, are incorporated into this guideline document. In addition, the panel added recommendations for management of histoplasmosis in children for those aspects that differ from aspects in adults.

UR - http://www.scopus.com/inward/record.url?scp=34848865974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848865974&partnerID=8YFLogxK

U2 - 10.1086/521259

DO - 10.1086/521259

M3 - Review article

C2 - 17806045

AN - SCOPUS:34848865974

VL - 45

SP - 807

EP - 825

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 7

ER -